{
    "clinical_study": {
        "@rank": "45075", 
        "acronym": "BENEMCOR", 
        "arm_group": [
            {
                "arm_group_label": "3 Month Load with 9 month p.r.n.", 
                "arm_group_type": "Active Comparator", 
                "description": "3 Monthly bevacizumab injections with 9 p.r.n. monthly doses if patient meets the treatment criteria for each monthly visit"
            }, 
            {
                "arm_group_label": "Single Dose Load Phase", 
                "arm_group_type": "Experimental", 
                "description": "Single dose treatment with bevacizumab, followed by 2 sham injections if conditions are met in the months 2 and 3, and followed with bevacizumab monthly p.r.n. as per protocol"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this protocol is to determine wether the initial protocol in the treatment of\n      subfoveal choroidal neovascularization associated to High Myopia with bevacizumab\n      intravitreal injections is more effective when using 3 doses vs using 1 single dose in the\n      load period"
        }, 
        "brief_title": "Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia", 
        "condition_browse": {
            "mesh_term": [
                "Myopia", 
                "Neovascularization, Pathologic", 
                "Choroidal Neovascularization"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Active subfoveal/juxtafoveal choroidal neovascularization in high myopia confirmed by\n             Fundus Fluorescein angiography and Optical Coherence Tomography\n\n          -  Best corrected visual acuity loss with less than 6 months of evolution, caused mainly\n             by the neovascular lesion (based in investigator\u00b4s criteria)\n\n          -  No atrophy or fibrotic component that may prevent visual acuity improvement\n\n          -  Patients previously treated with Photodynamic Therapy are allowed to participate in\n             this study\n\n          -  Signed informed consent\n\n          -  Signed data protection consent\n\n          -  Negative pregnancy test in potential childbearing women at screening, with accepted\n             contraceptive method during the whole study\n\n        Exclusion Criteria:\n\n          -  Previous vitreous surgery in study eye\n\n          -  Tractional maculopathy or epiretinal membrane found in Optical Coherence Tomography\n\n          -  Media opacities that may prevent correct fundus assessment\n\n          -  Lack of posterior capsule integrity in pseudophakic patients\n\n          -  Patients with great possibilities of not being able to attend to study visits /\n             follow visit procedures  (investigator\u00b4s criteria)\n\n          -  Patients previously treated with intravitreal antiangiogenic injections"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01716026", 
            "org_study_id": "IOBA-04-2012"
        }, 
        "intervention": {
            "arm_group_label": [
                "3 Month Load with 9 month p.r.n.", 
                "Single Dose Load Phase"
            ], 
            "description": "Intravitreal injection of bevacizumab", 
            "intervention_name": "Bevazizumab intravitreal injection", 
            "intervention_type": "Drug", 
            "other_name": "Avastin Injection"
        }, 
        "intervention_browse": {
            "mesh_term": "Bevacizumab"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "high myopia", 
            "choroidal neovascularization"
        ], 
        "lastchanged_date": "March 18, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Santiago de Compostela", 
                        "country": "Spain", 
                        "state": "La Coru\u00f1a", 
                        "zip": "15706"
                    }, 
                    "name": "CHUS - Fundacion IDICHUS"
                }, 
                "investigator": {
                    "last_name": "Ramon Gomez-Ulla, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "state": "Navarra", 
                        "zip": "31080"
                    }, 
                    "name": "Clinica Universitaria de Navarra"
                }, 
                "investigator": {
                    "last_name": "Alfredo Garcia Layana, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albacete", 
                        "country": "Spain", 
                        "zip": "02006"
                    }, 
                    "name": "Complejo Hospitalario de Albacete"
                }, 
                "investigator": {
                    "last_name": "Jose Maria Ruiz-Moreno, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28010"
                    }, 
                    "name": "Hospital Clinico Universitario San Carlos"
                }, 
                "investigator": {
                    "last_name": "Juan Donate, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28031"
                    }, 
                    "name": "Hospital Universitario Ram\u00f3n y Cajal"
                }, 
                "investigator": {
                    "last_name": "Marta Suarez de Figueroa, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murcia", 
                        "country": "Spain", 
                        "zip": "30100"
                    }, 
                    "name": "Hospital Reina Sofia"
                }, 
                "investigator": {
                    "last_name": "Inmaculada Selles, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Hospital Virgen de Valme"
                }, 
                "investigator": {
                    "last_name": "Antonio Pi\u00f1ero Bustamante, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41071"
                    }, 
                    "name": "Hospital Virgen de la Macarena"
                }, 
                "investigator": {
                    "last_name": "Eduardo Esteban, Gonzalez", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital General Universitario de Valencia"
                }, 
                "investigator": {
                    "last_name": "Enrique Cervera Taulet, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valladolid", 
                        "country": "Spain", 
                        "zip": "47011"
                    }, 
                    "name": "IOBA - Instituto Universitario de Oftalmobiologia Aplicada"
                }, 
                "investigator": {
                    "last_name": "Maria Isabel Lopez-Galvez, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valladolid", 
                        "country": "Spain", 
                        "zip": "47012"
                    }, 
                    "name": "Hospital Universitario Rio Hortega"
                }, 
                "investigator": {
                    "last_name": "Javier Montero Moreno, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Establishment of the Initial Protocol With Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization Associated With High Myopia:3 vs 1.", 
        "overall_contact": {
            "email": "jm.ruiz@umh.es", 
            "last_name": "Jose Maria Ruiz-Moreno, MD, PhD", 
            "phone": "610435999"
        }, 
        "overall_contact_backup": {
            "email": "maribel@ioba.med.uva.es", 
            "last_name": "Maria Isabel Lopez-Galvez, MD, PhD", 
            "phone": "34 983184734"
        }, 
        "overall_official": {
            "affiliation": "University of Castilla-La Mancha", 
            "last_name": "Jose Maria Ruiz-Moreno, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Differences in best corrected visual acuity in the exit visit compared to the one obtained at screening visit", 
                "measure": "Early Treatment Diabetic Retinopathy Study (ETDRS) Best corrected visual acuity", 
                "safety_issue": "No", 
                "time_frame": "1 Year"
            }, 
            {
                "description": "Retinal thickness assessed by Spectral Domain Optical Coherence Tomography", 
                "measure": "Retinal thickness", 
                "safety_issue": "No", 
                "time_frame": "1 Year"
            }, 
            {
                "description": "Total count of bevacizumab intravitreal injections during the whole study", 
                "measure": "Number of total injections during study", 
                "safety_issue": "No", 
                "time_frame": "1 Year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01716026"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Instituto Universitario de Oftalmobiolog\u00eda Aplicada", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Instituto Universitario de Oftalmobiolog\u00eda Aplicada", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}